Doctor profile · Federal record
Dr. Deepa Aravind, M.D
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Smithtown, NY
- NPI 1669677332
- Accepts Medicare
- MIPS 84.5 / 100 · 2023
- 25 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
285 Middle Country RD, Suite 105
Smithtown, NY 117872978
(631) 509-0390
fax (631) 656-0875
Credentials & registration
- NPI registered
- June 2007 — 19 yrs on file
- Profile last updated
- February 19, 2021
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- New York #2519631
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1669677332. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,944
Distinct HCPCS
9
Medicare allowed
$116,732
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 1,201 | 16 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 376 | 250 | $150 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 76 | 48 | $39 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 76 | 72 | $107 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 74 | 74 | $196 | |
83036 |
Hemoglobin a1c level | 68 | 64 | $10 | |
96372 |
Injection of drug or substance under skin or into muscle | 33 | 19 | $17 | |
10005 |
Fine needle aspiration biopsy using ultrasound guidance, first growth | 27 | 25 | $166 | |
10006 |
Fine needle aspiration biopsy using ultrasound guidance, each additional growth | 13 | 12 | $72 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 724. This provider delivers 2.7× the peer median.Open Payments
Industry payments received
All-time total
$1,052
Transactions
47
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | 8 | $186.58 | |
| Novo Nordisk Inc | 7 | $142.20 | |
| Xeris Pharmaceuticals, Inc. | 5 | $111.07 | |
| Lilly USA, LLC | 5 | $108.42 | |
| Dexcom, Inc. | 5 | $98.84 | |
| Abbott Laboratories | 4 | $74.67 | |
| Nevro Corp. | 3 | $62.86 | |
| Medtronic, Inc. | 1 | $54.74 | |
| Corcept Therapeutics | 2 | $53.81 | |
| Amgen Inc. | 2 | $36.93 | |
| ABBVIE INC. | 1 | $23.45 | |
| Insulet Corporation | 1 | $22.83 | |
| Tandem Diabetes Care, Inc. | 1 | $21.03 | |
| Radius Health, Inc. | 1 | $20.50 | |
| Verity Pharmaceuticals Inc. | 1 | $19.21 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,373
Patients
562
Total drug cost
$909,298
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 224 | 85 | $4,427 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 157 | 72 | $3,064 |
| Metformin Hcl | Generic | 153 | 69 | $1,703 |
| Ozempic (Semaglutide) | Brand | 101 | 42 | $194,987 |
| Mounjaro (Tirzepatide) | Brand | 96 | 27 | $137,562 |
| Jardiance (Empagliflozin) | Brand | 89 | 36 | $132,382 |
| Trulicity (Dulaglutide) | Brand | 81 | 25 | $175,038 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 72 | 31 | $99,199 |
| Synthroid (Levothyroxine Sodium) | Brand | 70 | 24 | $5,847 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 67 | 32 | $58,027 |
Hospital affiliations
Frequently asked questions
What is Dr. Deepa Aravind's medical specialty?
Dr. Deepa Aravind practices Endocrinology, Diabetes & Metabolism Physician in Smithtown, NY.
Where does Dr. Deepa Aravind practice?
Dr. Deepa Aravind practices at 285 Middle Country RD, Smithtown, NY 117872978. Office phone: 6315090390.
What is Dr. Deepa Aravind's NPI?
Dr. Deepa Aravind's National Provider Identifier (NPI) is 1669677332, issued by NPPES.
Does Dr. Deepa Aravind accept Medicare assignment?
Yes. Dr. Deepa Aravind accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Deepa Aravind commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251). Source: CMS Medicare Physician & Other Practitioners file.